Home > Insider Trading > Filing (0000899243-19-013509)

Filing Details

Accession Number:: 0000899243-19-013509
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-14 21:00:24
Reporting Period:: 2019-05-10

Accepted Time:: 2019-05-14 21:00:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1351288	Gw Pharmaceuticals Plc	GWPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532023	S Julian Gangolli	Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ	President, North America	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-05-10	403,804	$0.00	510,352	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-05-10	75,369	$10.61	585,721	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-05-10	192,755	$3.72	778,476	No	4	M	Direct
Ordinary Shares	Disposition	2019-05-10	117,876	$14.63	660,600	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	81,156	$14.70	579,444	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	65,268	$14.80	514,176	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	208,260	$14.88	305,916	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	145,164	$14.96	160,752	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	12,048	$15.03	148,704	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	31,368	$15.12	117,336	No	4	S	Direct
Ordinary Shares	Disposition	2019-05-10	10,788	$15.19	106,548	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Options	Disposition	2019-05-10	27,419	$0.00	27,419	$0.00
Ordinary Shares	Stock Options	Disposition	2019-05-10	365,591	$0.00	365,591	$0.00
Ordinary Shares	Stock Options	Disposition	2019-05-10	10,788	$0.00	10,788	$0.00
Ordinary Shares	Stock Options	Disposition	2019-05-10	75,369	$0.00	75,369	$10.61
Ordinary Shares	Stock Options	Disposition	2019-05-10	192,755	$0.00	192,755	$3.72
Ordinary Shares	Stock Options	Disposition	2019-05-10	6	$0.00	6	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-02-15	2020-03-15	No	4	M	Direct
0	2019-02-15	2020-03-15	No	4	M	Direct
0	2019-01-06	2020-03-15	No	4	M	Direct
0	2018-06-24	2025-06-24	No	4	M	Direct
0	2019-02-15	2026-02-15	No	4	M	Direct
10,603		2019-12-24	No	4	M	Direct

Footnotes

Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.30 U.S. Dollars as of May 10, 2019.
The exercise price was previously reported to be $8.7364 on the Reporting Person's form 3 filed with the SEC on October 1, 2018 due to an administrative error.
The exercise price was previously reported to be $3.3461 on the Reporting Person's form 3 filed with the SEC on October 1, 2018 due to an administrative error.
Represented by ADSs. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019.
The price reported in Column 4 is a weighted average price per ordinary share ($175.57 per ADS). These shares were sold in multiple transactions at prices ranging from $174.99 per ADS (or $14.58 per ordinary share) to $175.98 per ADS (or $14.67 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($176.40 per ADS). These shares were sold in multiple transactions at prices ranging from $175.99 per ADS (or $14.67 per ordinary share) to $176.87 per ADS (or $14.74 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($177.58 per ADS). These shares were sold in multiple transactions at prices ranging from $177.01 per ADS (or $14.75 per ordinary share) to $177.90 per ADS (or $14.83 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($178.60 per ADS). These shares were sold in multiple transactions at prices ranging from $178.02 per ADS (or $14.84 per ordinary share) to $179.00 per ADS (or $14.92 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($179.49 per ADS). These shares were sold in multiple transactions at prices ranging from $179.07 per ADS (or $14.92 per ordinary share) to $180.01 per ADS (or $15.00 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($180.36 per ADS). These shares were sold in multiple transactions at prices ranging from $180.13 per ADS (or $15.01 per ordinary share) to $180.44 per ADS (or $15.04 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($181.46 per ADS). These shares were sold in multiple transactions at prices ranging from $181.28 per ADS (or $15.11 per ordinary share) to $181.65 per ADS (or $15.14 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is price per ordinary share converted from price per ADS ($182.32 per ADS).
These stock options will originally vest on June 24, 2019. Stock options to acquire 6 ordinary shares were accelerated.